Patent 11466265 was granted and assigned to A-Alpha Bio on October, 2022 by the United States Patent and Trademark Office.
Provided herein are methods for identifying pairs of protein binding partners, mutations of which may inform the discovery of pharmaceutically useful small molecules. The methods disclosed herein may allow for the adaptation of the native protein degradation system to modulate specific disease targets at the protein level, in particular, for targets that have long been considered undruggable.